WeVote
Log In

Bill

Bill

HRES 1196

Recognizing April as Cancer Prevention and Early Detection Month.

119th Congress Introduced by Jodey Arrington and 14 co-sponsors

The bill elevates national focus on cancer prevention and early detection, urging education, collaboration, and action to reduce screening gaps and cancer burden.

Submitted in House
0
WeVote Research Nonpartisan
Bill Summary · HRES 1196

Summary of H.Res. 1196 (119th Congress) – Recognizing April as Cancer Prevention and Early Detection Month

1. Purpose and Intent

  • The resolution recognizes April as Cancer Prevention and Early Detection Month.
  • It expresses a renewed national commitment to disease prevention, early detection, and reducing the burden of cancer in the United States.
  • It highlights the importance of education, awareness, and collaboration among federal agencies, healthcare providers, researchers, and advocates to improve early cancer detection and prevention.

2. Key Provisions and Changes

As a House resolution, H.Res. 1196 does not create new law or allocate funding. Its provisions are statements of purpose and policy:

  • Acknowledges that early detection and prevention can transform cancer outcomes, reduce mortality, and lower long-term healthcare costs.
  • Emphasizes that despite declines in overall cancer mortality due to advances in screening and treatment, gaps in cancer screening persist that could be addressed to save lives.
  • Highlights the benefits of early diagnosis: diagnosing cancers at earlier, more treatable stages reduces the need for intensive intervention and can lower costs and improve survival.
  • Calls for addressing barriers to screening access, including:
    • Lack of knowledge about screening benefits
    • Cost concerns
    • Other structural factors within the health care system
  • Points out that up to 50% of cancer cases and up to 50% of cancer deaths are potentially preventable with knowledge and preventive actions (e.g., risk-based screenings, vaccines, lifestyle factors).
  • Identifies actionable preventive measures that reduce cancer risk and improve early detection, such as:
    • Understanding family health history
    • Risk-based screenings
    • Avoiding tobacco, limiting alcohol
    • Skin protection
    • Physical activity and a balanced diet
    • Reducing exposure to cancer-related infections
    • Receiving recommended vaccinations
  • Acknowledges disparities: gaps in screening disproportionately affect certain populations and care may be less accessible to medically underserved individuals.
  • Stresses the federal role in supporting early detection programs, especially in hard-to-serve populations, and in shaping regulatory and administrative frameworks for cancer screening technologies and access to treatments.
  • Recognizes collaboration among stakeholders (advocates, medical professionals, researchers, policymakers) as essential to save lives through early detection.
  • Reiterates that April has been designated Cancer Prevention and Early Detection Month.

3. Who or What Is Affected

  • The resolution targets national awareness and policy priorities rather than specific regulatory changes or funding mechanisms.
  • It addresses:
    • Individuals at risk for cancer (emphasizing prevention and early detection actions)
    • Patients across the cancer care continuum (prevention, screening, diagnosis, treatment)
    • Populations facing barriers to screening (hard-to-serve, medically underserved, underserved communities)
    • Federal agencies involved in cancer screening regulatory and administrative processes (for alignment with prevention and early detection goals)
    • Healthcare providers, researchers, and advocates involved in cancer prevention and early detection efforts

4. Procedural and Timeline Aspects

  • Introduced in the 119th Congress on April 20, 2026.
  • Referred to the House Committee on Energy and Commerce.
  • As a concurrent or non-binding resolution, it serves to express the sense of the House and does not itself create enforceable statutory requirements or funding.
  • No specific dates, funding mechanisms, or regulatory timelines are established in the text of the resolution.

5. Sponsors (Selected)

  • Primary sponsor: Mr. Miller (Ohio)
  • Co-sponsors include: Ms. Sewell, Mr. Fitzpatrick, Ms. Wasserman Schultz, Mr. Buchanan, Ms. Tenney, Ms. Salazar, Mr. Arrington, Mr. Moulton, Ms. Tenn(e)y, Mr. Bean, Mr. Carey, Ms. Dingell, Ms. Stansbury, and others.

6. Practical Impact

  • Elevates national emphasis on cancer prevention and early detection.
  • Encourages continued and expanded education, outreach, and collaboration to reduce screening gaps.
  • Signals bipartisan support for prioritizing early detection as a means to reduce cancer burden and improve health outcomes, without mandating new programs or funding in this bill.

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.